The paradox of improved antiretroviral therapy in HIV: Potential for nutritional modulation?

Proceedings of the Nutrition Society

Volumn 61, Issue 1, 2002, Pages 131-136

  Ware, Lisa J ^a   Wootton, S A ^a   Morlese, J M ^b   Gazzard, B G ^b   Jackson, A A ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

HIV; Lipids; Lipodystrophy; Metabolism; Stable isotopes

Indexed keywords

ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; CHOLESTEROL; FATTY ACID; LIPOPROTEIN LIPASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADIPOSE TISSUE; CONFERENCE PAPER; DIETARY INTAKE; DRUG INDUCED DISEASE; FAT INTAKE; FATTY ACID METABOLISM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; VIRUS INFECTION; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIETARY FATS; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; LIPODYSTROPHY; SYNDROME; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036180495     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2001139     Document Type: Article

References (50)

1. Dietary intake, serum lipids, insulin resistance and body composition in the era of HAART 'Diet FRS Study'
2. Dietary fish oil and cytokine production during HIV infection
3. Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway
4. Mitochondrial toxicity induced by nucleoside-analogue reverse transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
5. Effects of fatty acids and dietary lipids on cells of the immune system
6. Adverse effects of antiretroviral therapy
7. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
8. Diagnosis, prediction and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
9. Serum lipid concentration with reference to the clinical and immunological status of HIV infected men
10. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology
11. Plasma lipids in HIV-infected patients: A prospective study in 95 patients
12. Fatty acids and plasma antioxidants in HIV-positive patients: Correlation with nutritional and immunological status
13. Messengers and mediators: Interactions among lipids, eicosanoids and cytokines
14. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells
15. Diet affects the mechanisms by which TNF stimulates hepatic triglyceride production
16. Lipoprotein alterations in patients with HIV infection: Relation with cellular and humoral immune markers
17. Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition
18. Weight loss and diarrhoea
19. Prognostic value of triglyceride levels in early HIV infection
20. The metabolic effects of tumour necrosis factor and other cytokines
21. Metabolic disturbances and wasting in AIDS
22. Circulating IFN-alpha and hypertriglyceridaemia in AIDS
23. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome
24. Increased de novo hepatic lipogenesis in HIV infection
25. Resting energy expenditure and substrate oxidation in HIV-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage
26. Erythrocyte glutathione deficiency in symptom-free HIV infection is associated with decreased synthesis rate
27. Progress of HIV infection and changes in the lipid membrane structure of CD4+ cells
28. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection
29. HIV Infection: A model chronic illness for studying wasting diseases
30. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
31. Atherogen lipid profile in HIV-1 infected patients with lipodystrophy syndrome
32. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women
33. Protease inhibitors, diabetes mellitus and blood lipids
34. Anabolic effects of recombinant human growth hormone in patients with wasting associated with HIV infection
35. Absent HIV infection, Indinavir causes insulin resistance
36. Steroid hormone, cytokine, lipid and metabolic disturbances in HIV infection
37. Serum vitamin E decreases in HIV-seropositive subjects over time
38. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
39. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution
40. Vitamin, trace element and peroxide status in HIV seropositive patients: Asymptomatic patients present a severe betacarotene deficiency
41. The effect of protease inhibitors on weight and body composition in HIV-infected patients
42. Marked hypertriglyceridaemia associated with ritonavir therapy
43. Insulin resistance and lipoprotein metabolism
44. Long term use of lovastatin in different types of hyperlipidaemia
45. Fasting increases plasma membrane fatty acid-binding protein in red skeletal muscle
46. Differences in postprandial lipid metabolism in patients with PI-associated and NRTI-associated lipodystrophy
47. Highly active anti-retroviral therapy (HAART) in HIV-1 positive men increases the retention time of dietary lipid within the circulation
48. Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
49. Resistance exercise training reduces hypertriglyceridaemia in HIV-infected men treated with antiviral therapy